President’s Cancer Panel calls for improved equity and access as cancer screening rates lag

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Mary Beckerle, a whitewater kayaker, has advice for all the folks in the cancer field: never catastrophize, never panic.

In The Headlines: A good week for NIH, a bad week for Vinay Prasad

While doing somewhat-routine reporting on this year’s Senate Appropriations Committee bills, Paul Goldberg, editor and publisher of The Cancer Letter, quickly realized that he was seeing a full bipartisan rejection of President Donald J. Trump’s plan to defund and therefore dismantle biomedical research in the United States.

August 06, 2025

Vol.51 No.30

Clinical Roundup

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Reduced screening rates and a higher prevalence of triple-negative breast cancer are driving elevated rates of advanced breast cancer in a geographic hotspot in Wilmington, Delaware, according to findings by researchers at ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute.

July 25, 2025

Vol.51 No.29

Clinical Trials & Tribulations

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Our Hispanic community is a vibrant and essential part of the American tapestry, contributing richly to the country’s society, culture, and economy. Yet, when it comes to healthcare, this community grapples with significant disparities, especially in cancer care.

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

Cancer Policy

House passes Trump’s spending bill, which now moves to the Senate

The U.S. House of Representatives voted on the so-called “One Big, Beautiful Bill Act,” this week which included drastic, $715 billion cuts to Medicaid that will result in at least 8.6 million people losing health insurance coverage, including cancer patients and survivors.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

President’s Cancer Panel calls for improved equity and access as cancer screening rates lag

YOU MAY BE INTERESTED IN

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

In The Headlines: A good week for NIH, a bad week for Vinay Prasad

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

House passes Trump’s spending bill, which now moves to the Senate

Renew today!

Subscriber content

Never miss an issue!

Login

President’s Cancer Panel calls for improved equity and access as cancer screening rates lag

YOU MAY BE INTERESTED IN

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five statesHonoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

In The Headlines: A good week for NIH, a bad week for Vinay Prasad

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

House passes Trump’s spending bill, which now moves to the Senate

Never miss an issue!

Login

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”